BERKELEY, Calif.--(BUSINESS WIRE)--April 27, 2005--BioTime, Inc. (AMEX:BTX) announced that on April 21, 2005, it received notice from the staff of the American Stock Exchange indicating that BioTime does not meet certain of the Exchange’s continued listing standards as set forth in Section 1003(a)(iii) of the AMEX Company Guide in that BioTime has shareholders’ equity of less than $6,000,000 and has incurred losses during the last five fiscal years. Accordingly, the staff of the Exchange has determined to proceed with the filing of an application to the Securities and Exchange Commission under Securities Exchange Act Rule 12d-2 to delist BioTime common stock and warrants from the Exchange.
